Dendritic cells restrict the transformation of Histoplasma capsulatum conidia into yeasts

Medical Mycology

Volumn 49, Issue 4, 2011, Pages 356-364

  Newman, Simon L ^a   Lemen, Wendy ^a   Smulian, Alan G ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

conidia; dendritic cells; Histoplasma capsulatum; macrophages; yeasts

Indexed keywords

GREEN FLUORESCENT PROTEIN;

ARTICLE; CONIDIUM; DENDRITIC CELL; FLUORESCENCE MICROSCOPY; HISTOPLASMA CAPSULATUM; HISTOPLASMOSIS; HUMAN; LUNG ALVEOLUS; MACROPHAGE; NONHUMAN; PHAGOCYTOSIS; PHASE CONTRAST MICROSCOPE; QUANTITATIVE ANALYSIS; YEAST;

ANIMALS; CELLS, CULTURED; DENDRITIC CELLS; GREEN FLUORESCENT PROTEINS; HISTOPLASMA; HUMANS; MACROPHAGES; MICE; PHAGOCYTOSIS; SPORES, FUNGAL;

AJELLOMYCES CAPSULATUS; MURINAE;

EID: 79955017505     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693786.2010.531295     Document Type: Article

References (38)

1. Wheat LJ, Slama TG, Norton JA, et al. Risk factors for disseminated or fatal histoplasmosis. Analysis of a large urban outbreak. Ann Intern Med 1982; 96: 159-163. (Pubitemid 12172328)
2. Wheat LJ, Smith EJ, Sathapatayavongs B, et al. Histoplasmosis in renal allograft recipients. Two large urban outbreaks. Arch Intern Med 1983; 143: 703-707. (Pubitemid 13161837)
3. Wood KL, Hage CA, Knox KS, et al. Histoplasmosis after treatment with anti-tumor necrosis factor-alpha therapy. Am J Respir Crit Care Med 2003; 167: 1279-1282. (Pubitemid 36555102)
4. Antinori S, Magni C, Nebuloni M, et al. Histoplasmosis among human immunodef ciency virus-infected people in Europe: report of 4 cases and review of the literature. Medicine (Baltimore) 2006; 85: 22-36. (Pubitemid 43884284)
5. de Francesco Daher E, de Sousa Barros FA, da Silva Junior GB, et al. Risk factors for death in acquired immunodef ciency syndrome-associated disseminated histoplasmosis. Am J Trop Med Hyg 2006; 74: 600-603.
6. Jain VV, Evans T, Peterson MW Reactivation histoplasmosis after treatment with anti-tumor necrosis factor alpha in a patient from a nonendemic area. Respir Med 2006; 100: 1291-1293. (Pubitemid 43793058)
7. de Monbreun WA. Cultivation and cultural characteristics of Darling's Histoplasma capsulatum. Am J Trop Med 1934; 14: 93-135.
8. Howell A. Studies on Histoplasma capsulatum and similar form spe-cies. 1. Morphology and development Mycologia 1939; 31: 191-216.
9. Deepe GS, Bullock WE. Histoplasmosis: A granulomatous inf amma-tory response. In: Gallin JI, Goldstein IM, Snyderman R, (eds.), Inf ammation: Basic Principles and Clinical Correlates. New York: Raven Press; 1992: 943-958.
10. Procknow JJ, Page MI, Loosli CG. Early pathogenesis of experimen-tal histoplasmosis. Arch Pathol 1960; 69: 413-426.
11. Baughman RP, Kim CK, Vinegar A, et al. The pathogenesis of experi-mental pulmonary histoplasmosis. Correlative studies of histopathol-ogy, bronchoalveolar lavage, and respiratory function. Am Rev Respir Dis 1986; 134: 771-776. (Pubitemid 16008643)
12. Deepe GS, Jr., Gibbons RS, Smulian AG. Histoplasma capsulatum manifests preferential invasion of phagocytic subpopulations in mu-rine lungs. J Leukoc Biol 2008; 84: 669-678.
13. Deepe GS, Jr., Seder RA. Molecular and cellular determinants of im-munity to Histoplasma capsulatum. Res Immunol 1998; 149: 397-406; discussion 509-310. (Pubitemid 28372456)
14. Newman SL. Cell-mediated immunity to Histoplasma capsulatum. Semin Respir Infect 2001; 16: 102-108. (Pubitemid 32606847)
15. Newman SL, Bucher C, Rhodes J, Bullock WE. Phagocytosis of His-toplasma capsulatum yeasts and microconidia by human cultured mac-rophages and alveolar macrophages. Cellular cytoskeleton requirement for attachment and ingestion. J Clin Invest 1990; 85: 223-230. (Pubitemid 20030313)
16. Gildea LA, Morris RE, Newman SL. Histoplasma capsulatum yeasts are phagocytosed via very late antigen-5, killed, and processed for antigen presentation by human dendritic cells. J Immunol 2001; 166: 1049-1056. (Pubitemid 32060262)
17. Klimpel KR, Goldman WE. Isolation and characterization of spon-taneous avirulent variants of Histoplasma capsulatum. Infect Immun 1987; 55: 528-533. (Pubitemid 17021935)
18. Smulian AG, Gibbons RS, Demland JA, Spaulding DT, Deepe GS, Jr. Expression of hygromycin phosphotransferase alters virulence of Histoplasma capsulatum. Eukaryot Cell 2007; 6: 2066-2071. (Pubitemid 350221275)
19. Kugler S, Young B, Miller VL, Goldman WE. Monitoring phase-specif c gene expression in Histoplasma capsulatum with telomeric GFP fusion plasmids. Cell Microbiol 2000; 2: 537-547. (Pubitemid 32049323)
20. Newman SL, Musson RA, Henson PM. Development of functional complement receptors during in vitro maturation of human monocytes into macrophages. J Immunol 1980; 125: 2236-2244. (Pubitemid 10022972)
21. Newman SL, Gootee L, Hilty J, Morris RE. Human macrophages do not require phagosome acidif cation to mediate fungistatic/fungicidal activ-ity against Histoplasma capsulatum. J Immunol 2006; 176: 1806-1813. (Pubitemid 43134325)
22. Newman SL, Gootee L. Colony-stimulating factors activate human macrophages to inhibit intracellular growth of Histoplasma capsula-tum yeasts. Infect Immun 1992; 60: 4593-4597.
23. Maresca B, Kobayashi GS. Dimorphism in Histoplasma capsula-tum: a model for the study of cell differentiation in pathogenic fungi. Microbiol Rev 1989; 53: 186-209. (Pubitemid 19147491)
24. Kimberlin CL, Hariri AR, Hempel HO, Goodman NL. Interactions between Histoplasma capsulatum and macrophages from normal and treated mice: comparison of the mycelial and yeast phases in alveolar and peritoneal macrophages. Infect Immun 1981; 34: 6-10. (Pubitemid 11004934)
25. Hempel H, Goodman NL. Rapid conversion of Histoplasma capsu-latum, Blastomycesdermatitidis and Sporothrix schenckii in tissue culture. J Clin Microbiol 1975; 1: 420-424.
26. Cano LE, Brummer E, Stevens DA, Restrepo A. Fate of conidia of Paracoccidioides brasiliensis after ingestion by resident macrophages or cytokine-treated macrophages. Infect Immun 1992; 60: 2096-2100.
27. Gonzalez A, de Gregori W, Velez D, Restrepo A, Cano LE. Nitric ox-ide participation in the fungicidal mechanism of gamma interferon-activated murine macrophages against Paracoccidioides brasiliensis conidia. Infect Immun 2000; 68: 2546-2552. (Pubitemid 30253824)
28. Gonzalez A, Restrepo A, Cano LE. Role of iron in the nitric oxide-mediated fungicidal mechanism of IFN-gamma-activated murine macrophages against Paracoccidioides brasiliensis conidia. Rev Inst Med Trop Sao Paulo 2007; 49: 11-16. (Pubitemid 46475129)
29. Gonzalez A, Aristizabal BH, Gomez EC, Restrepo A, Cano LE. Short report: Inhibition by tumor necrosis factor-alpha-activated macrophages of the transition of Paracoccidioides brasiliensis conid-ia to yeast cells through a mechanism independent of nitric oxide. Am J Trop Med Hyg 2004; 71: 828-830. (Pubitemid 40075637)
30. Cano LE, Arango R, Salazar ME, et al. Killing of Paracoccidioides brasiliensis conidia by pulmonary macrophages and the effect of cy-tokines. J Med Vet Mycol 1992; 30: 161-168.
31. McEwen JG, Bedoya V, Patino MM, Salazar ME, Restrepo A. Experimental murine paracoccidiodomycosis induced by the inhala-tion of conidia. J Med Vet Mycol 1987; 25: 165-175.
32. Sugar AM, Picard M. Macrophage-and oxidant-mediated inhibition of the ability of live Blastomyces dermatitidis conidia to transform to the pathogenic yeast phase: implications for the pathogenesis of dimorphic fungal infections. J Infect Dis 1991; 163: 371-375.
33. Sugar AM, Picard M, Wagner R, Kornfeld H. Interactions between human bronchoalveolar macrophages and Blastomyces dermatitidis conidia: demonstration of fungicidal and fungistatic effects. J Infect Dis 1995; 171: 1559-1562.
34. Beaman L, Holmberg CA. In vitro response of alveolar macrophag-es to infection with Coccidioides immitis. Infect Immun 1980; 28: 594-600. (Pubitemid 10102100)
35. Ampel NM, Galgiani JN. Interaction of human peripheral blood mononuclear cells with Coccidioides immitis arthroconidia. Cell Immunol 1991; 133: 253-262.
36. Kudeken N, Kawakami K, Saito A. Different susceptibilities of yeasts and conidia of Penicillium marneffei to nitric oxide (NO)-mediated fungicidal activity of murine macrophages. Clin Exp Immunol 1998; 112: 287-293. (Pubitemid 28266689)
37. Roilides E, Lyman CA, Sein T, Petraitiene R, Walsh TJ. Macrophage colony-stimulating factor enhances phagocytosis and oxidative burst of mononuclear phagocytes against Penicillium marneffei conidia. FEMS Immunol Med Microbiol 2003; 36: 19-26. (Pubitemid 36515079)
38. Gildea LA, Ciraolo GM, Morris RE, Newman SL. Human den-dritic cell activity against Histoplasma capsulatum is mediated via phagolysosomal fusion. Infect Immun 2005; 73: 6803-6811. (Pubitemid 41368847)